Moreover, hyperinsulinemia resulting from insulin resistance can also contribute to cognitive impairment in DE through pathways involving β-amyloid deposition, tau phosphorylation, oxidative stress, inflammation, and synaptic plasticity, thereby increasing the risk of DE. The gene discussed is MAPT; the disease is Cognitive impairment.